American Journal of Ophthalmology
Volume 149, Issue 4 , Pages 537-539 , April 2010

Global Corneal Blindness and the Boston Keratoprosthesis Type I

  • Jared D. Ament

      Affiliations

    • Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • ,
  • Amit Todani

      Affiliations

    • Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • ,
  • Roberto Pineda II

      Affiliations

    • Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • ,
  • Tueng T. Shen

      Affiliations

    • University of Washington Eye Institute, University of Washington, Seattle, Washington
  • ,
  • Anthony J. Aldave

      Affiliations

    • Jules Stein Eye Institute, The University of California, Los Angeles, Los Angeles, California
  • ,
  • Claes H. Dohlman

      Affiliations

    • Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • ,
  • James Chodosh

      Affiliations

    • Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationInquiries to James Chodosh, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114

,Accepted 1 November 2009.

References 

  1. World Health Organization. Visual impairment and blindness. http://www.who.int/mediacentre/factsheets/fs282/en/Accessed August 20, 2009
  2. Whitcher JP, Srinivasan M, Upadhyay MP. Bull World Health Org. 2001;79:214–221
  3. Upadhyay MP, Karmacharya PC, Koirala S, et al. The Bhaktapur eye study: ocular trauma and antibiotic prophylaxis for the prevention of corneal ulceration in Nepal. Br J Ophthalmol. 2001;85:388–392
  4. World Health Organization. Global initiative for the elimination of avoidable blindness (Unpublished document WHO/PBL/97.61/Rev 1). Geneva: World Health Organization, Prevention of Blindness and Deafness; 1997;http://whqlibdoc.who.int/hq/1997/WHO_PBL_97.61_Rev.1.pdfAccessed August 20, 2009
  5. Raychaudhuri A, Raychaudhuri M, Banerjee AR. Availability of donor corneal tissue for transplantation. Trop Doct. 2004;34:99–101
  6. Dohlman CH. Guillaume Pellier. In:  Mannis MJ,  Mannis AA editor. Corneal Transplantation: A History in Profiles (Hirschberg History of Ophthalmology). Oostende, Belgium: JP Wayenborgh; 1999;p. 53–64
  7. Dohlman CH, Harissi-Dagher M, Khan BF, Sippel K, Aquavella JV, Graney JM. Introduction to the use of the Boston keratoprosthesis. Expert Rev Ophthalmol. 2006;1:41–48
  8. Massachusetts Eye and Ear Infirmary. Boston keratoprosthesis update. Newsletter VI; 2009;http://www.kpro.org/wp-content/uploads/2009/09/2009-kpro-newsletter-pdf.pdfAccessed February 21, 2010
  9. Zerbe BL, Belin MW, Ciolino JB. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology. 2006;113:1779e1–1779e7
  10. Aldave AJ, Kamal KM, Vo RC, Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116:640–651
  11. Dohlman C, Dudenhoefer E, Khan BF, Morneault S. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J. 2002;28:72–74
  12. Bersudsky V, Blum-Hareuveni T, Rehany U, Rumelt S. The profile of repeated corneal transplantation. Ophthalmology. 2001;108:461–469
  13. Ament JD, Pineda R, Lawson B, Behlau I, Dohlman CH. The Boston keratoprosthesis: international protocol. Version 2 http://www.masseyeandear.org/gedownload!/KPro%20International%20Protoc012.pdf?item_id=5816015&version_id=5816016June 15, 2009;Accessed August 20, 2009
  14. Ament JD, Stryjewski TP, Ciolino JB, Todani A, Chodosh J, Dohlman CH. Cost-Effectiveness of the Boston Keratoprosthesis. Am J Ophthalmol. 2010;149:221–228

PII: S0002-9394(09)00800-9

doi: 10.1016/j.ajo.2009.11.001

American Journal of Ophthalmology
Volume 149, Issue 4 , Pages 537-539 , April 2010